Related Experiment Video
Updated: Jul 8, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Update on diabetes diagnosis and management
Carolyn Robertson1, Andrew Jay Drexler, Anthony T Vernillo
1New York Diabetes Program, New York, NY 10016, USA. nydiabetes@aol.com
Journal of the American Dental Association (1939)
|January 17, 2008
Summary
Maintaining rigorous diabetes control is achievable through combined therapies and target outcomes. Dentists play a role in prevention and referral, collaborating with physicians for optimal patient metabolic health.
Area of Science:
- Endocrinology
- Preventive Medicine
- Dental Public Health
Background:
- The American Diabetes Association recommends screening for undiagnosed diabetes.
- Effective glucose control is crucial for individuals with diabetes to achieve near-normal metabolism.
- Dentists can identify at-risk individuals and refer suspected cases for medical evaluation.
Purpose of the Study:
- To outline diagnostic criteria and risk identification for diabetes.
- To present a comprehensive approach to managing type 1 and type 2 diabetes mellitus.
- To define target outcomes for diabetes management.
Main Methods:
- Review of diagnostic criteria for diabetes.
- Description of risk assessment strategies for diabetes development.
- Presentation of combined medical management approaches for diabetes.
Main Results:
- Target glycosylated hemoglobin levels should not exceed 7 percent for patients with diabetes.
- Emerging research includes islet cell transplantation and therapeutic cloning for potential diabetes cures.
- These novel therapies aim to provide alternative sources of insulin-producing cells.
Conclusions:
- Rigorous metabolic control in diabetes is attainable through integrated therapeutic strategies and outcome management.
- Dentists can implement preventive measures and refer patients exhibiting diabetes symptoms to physicians.
- A collaborative dentist-physician approach is essential for achieving optimal diabetes control.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...